The B-Raf proto-oncogene serine / threonine-protein (BRAF) V600E mutation has been focused on by researchers as a potential oncogenic factor in many types of cancer [12–14], such as papillary thyroid cancer, colorectal cancer, melanoma, and gliomas in both adult and pediatric populations. This evidence concerns the gene BRAF and central nervous system cancer.